Unregulated Antibiotic Sales Drive Drug Resistance Development, U.K. Review Panel Says

Reuters: Unregulated antibiotic sales may increase risk of “superbugs”: U.K. review
“Global growth of unregulated over-the-counter and Internet sales of precious antibiotic medicines is further fueling the rise of deadly, drug-resistant ‘superbug’ bacteria, according to a U.K. government-commissioned review. … In a report published on Friday …, former Goldman Sachs chief economist Jim O’Neill said the threat is exacerbated by patients self-medicating with drugs from online pharmacies…” (Kelland, 11/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.